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Summary: 
What effect did the dramatic expansion in long distance trade in the 
early modern period have on healthcare in England? This paper 
presents new evidence on the scale, origins and content of English 
imports of medical drugs between 1567 and 1774. It shows that the 
volume of medical drugs imported exploded in the seventeenth 
century, and continued growing more gradually over the eighteenth 
century. The variety of drugs imported changed more slowly. Much 
was re-exported, but estimates of dosages suggest that some 
common drugs (e.g.: senna, Jesuits’ bark) were available to the 
majority of the population in the eighteenth century. English 
demand for foreign drugs provides further evidence for a radical 
expansion in medical consumption in the seventeenth century. It 
also suggests that much of this new demand was met by 
purchasing drugs rather than buying services.  
 
 
What effects did the dramatic expansion in long distance trade in 
the early modern period have on healthcare in England? European 
demand for drugs and spices is widely recognised as one of the driving 
forces of international commerce. While the volume and price of the major 
spices such as pepper and cloves have been much studied, the impact 
that increasing levels of trade had on the wider array of primarily medical 
drugs and its consequences for medical practice is largely unknown.2 
Beyond some import figures for 1567 to 1638 compiled by Roberts, and 
Davis’ aggregate values for drug imports over the eighteenth century, no 
estimates exist for English imports or consumption.3 This neglect is 
                                                 
1 Acknowledgements to follow. Research Assistance: Carlos Santiago Caballero; 
Elizabeth Williamson; Carlos Brando; Nat Ishino. 
2 Recent discussions include: Findlay and O’Rourke 2007; O’Rourke and Williamson, 
2002; O’Rourke and Williamson, 2009; Halikowksi Smith 2008. 
3 Roberts 1965; Davis 1954; Davis 1962. 
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surprising given the importance of imported goods such as sugar, tea, 
tobacco, and calicos to analyses of consumption more generally, and the 
growing interest in perceptions of exotic drugs and their impact on natural 
philosophy.4  
In this paper, I present new evidence on the trajectory of the 
English medical drug trade between 1567 and 1774 showing that 
consumption of imported medical drugs exploded in the seventeenth 
century and continued growing more gradually over the eighteenth 
century. Medicines flooded in alongside other commodities as England 
moved from being the last step on a long supply chain that crossed 
Europe and the Levant to a major entrepôt for the rest of the continent. 
This account of medical drugs has relevance to general histories of 
consumption: by considering the full range of old and new medical drugs 
imported it allows an insight into the significance of novelties in inspiring 
consumption, and by covering a longer period than most studies it permits 
longer run trends to be identified. More specifically, understanding the 
dramatic changes in the volume and type of drugs that were imported 
between the sixteenth and eighteenth centuries allows us to engage with 
two central issues in the history of early modern medicine. The first is the 
timing and scale of the shift in English demand for commercially-supplied 
healthcare. The second is whether the very significant theoretical 
changes in medicine in this period were reflected in what people used as 
drugs: or how quickly, and how extensively, was the character of 
medicine changing?  
The availability of imported drugs offers a distinctive measure of 
healthcare consumption. Most studies to date have focussed on the 
personnel supplying healthcare rather than the materials involved, 
                                                 
4 On consumption: Peck 2005; Berg 2005; De Vries 2008; McCants 2007. On natural 
philosophy and exotics: Smith and Findlen 2002; Cook 2008, pp. 191-225; 
Winterbottom, 2009; Anagnostou, 2007. 
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exploring the density of practitioners, the activities of particular individuals 
and groups of medical practitioners, and, more recently, the frequency of 
resort to practitioners among the seriously ill.5 By developing this last 
method, Ian Mortimer has quantified levels of demand for medical 
services in Southern England over the seventeenth century, concluding 
that an increase of between 400 and 1,000 percent occurred from 1620 to 
1690.6 Examining drug imports allow us to extend and contextualize 
Mortimer’s analysis: drug imports suggest whether his account of 
responses to serious illness extends to a wider variety of conditions; they 
show how the trajectory of consumption developed over the century after 
his study ends; and they reveal national, rather than regional, patterns. By 
examining the types of drugs imported, we can also explore one of the 
main explanatory hypotheses Mortimer put forwards for the increase in 
consumption that he observed: a shift in the type of medicine used from 
Galenic to chemical or Paracelsian medicine.7  
The volume and price of imported drugs is, of course, only an 
indirect measure of the degree to which the population was utilising a 
particular kind of healthcare. Medicine also made much use of home-
grown drugs and other substances, various plants were domesticated in 
English physic gardens in this period, substitutes for imported drugs were 
available, and medicines were only one part of the art of physic, 
alongside diet, exercise and other non-naturals.8 Some practitioners 
appear to have used remedies in only a minority of cases.9 Nonetheless, 
foreign drugs were an important part of the therapeutic core of much 
commercial medicine, particularly in Galenic physic. They were also 
central to the retail trade in medical substances; they were the mainstay 
                                                 
5 Pelling and Webster 1979; Pelling 2003, pp.136-224; Wilson 1995, pp. 161-9; 
Mortimer 2009. 
6 Mortimer 2009, pp. 39-40. 
7 Mortimer 2009, pp. 65, 90, 207. 
8 Stobart 2008, pp. 153-65; Leong 2006, pp. 98-103; Wear 2000, pp. 46-78. 
9 Kassell 2005, pp. 154-7.  
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of the remedies sold in the shops of apothecaries, druggists, and other 
retailers.10 For a medicine established and fostered around the shores of 
the Mediterranean, the heartland of the pharmacopoeia inevitably lay far 
to the south of England’s shores. If imports of medical drugs were not 
arriving in large quantities, then we can reasonably presume that this 
form of medicine was not being used widely, and vice versa.  
 
 
Sources and Method 
English drug imports and exports are recorded in two main 
locations: for the sixteenth and seventeenth centuries, Port Books contain 
undifferentiated lists of the cargoes of ships which were noted down as 
they entered and left the country; from 1696, overseas trade is 
summarised in the annual ledgers of the Inspector-General of the 
Customs. These records were kept as part of the process by which 
customs’ duties were collected. Because of this, both the Port Books and 
the Ledgers have a number of limitations. Goods imported or exported 
duty-free were not recorded.11 The estimates of value they contain were 
based on dubious prices and calculations. Incorrect entries at the 
customs house are also an issue: false entries are a feature of the 
system, particularly for geographical information, where monopolies of 
colonial trade supplied motives for lying about origins and destinations of 
goods.12  More importantly, drugs may have been smuggled to avoid tax, 
despite its relatively low rate for the early part of the period.13 
Port Books and Ledgers also present particular practical 
challenges. First, Port Book survival is geographically patchy. 14 
                                                 
10 Wallis 2002, pp. 194-8. 
11 Willan 1962, p. x. 
12 Clark 1938, pp. 33-37; Hoon 1937, p. 257; Ashworth 2003, pp.133--64. 
13 Ashworth 2003, pp. 165-83. 
14 Several Port Books used by Roberts are no longer fit for production. 
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Fortunately, survival appears to be best for London, the epicentre of the 
drug trade. I take London’s records as a proxy for national import totals 
before 1699: extant records for other ports indicate that few drugs entered 
elsewhere, and at the end of the seventeenth century, when the Ledgers 
allow us to compare London and the outports, almost 95 per cent of drugs 
arrived in London. 15 Second, the Port Books are an un-indexed list 
written in cramped and variable handwriting. Identifying drugs is therefore 
a slow process that is vulnerable to errors: the figures obtained are, as a 
result, minimum estimates of the quantities imported.16  
Third, Port Books only survive for certain years, or even part years. 
Trade by English and foreign (alien) merchants was recorded in separate 
volumes, and sometimes only one survives.17 These years may be 
unrepresentative, as trade varied with war, economic fluctuations, 
blockades, epidemics and fires. Such events undoubtedly affected some 
of the years utilized here, for example 1567 was three years after the 
disruption caused by the English embargo on foreign shipping (1563-4) 
and just before political crisis severely disrupted Dutch trade, while 1617 
coincides with the Cockayne project.18  
Survival is poor enough that for 1567 to 1640, I use all accessible 
surviving Port Books for imports into London. For 1663 and 1669, a set of 
                                                 
15 No drugs were listed among imports in the Liverpool port book for 1665 (The 
National Archives [hereafter TNA], E190/1337/16); in 1709 the port book (TNA, 
E190/1375/08) recorded imports of Sarsaparilla of 1,533 lb; exports that year included 
19lb of apothecary wares: Power, Lewis and Ascott 1998.  
16 Errors and omissions in Roberts’ figures meant they could not be relied on here. For 
the data before 1699, all individual drug consignments that were substantial enough to 
affect the total for a year (making up >5% of the annual total by value) were re-
checked, as were any imports that differed markedly from the norm (by volume) for that 
product. The net effect of the data cleaning process is to further bias these figures 
downwards, as excessively large consignments were checked and corrected when 
errors were found, but low figures were not. As well as similar tests for errors, the data 
for 1699-1774 was all manually re-checked against the original Ledgers.  
17 Data corrections are summarised in the note to table 1.  
18 De Vries and Van der Woude 1997, pp. 363-4; Dietz 1971. 
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near-contemporary totals for commodities imported survive.19 For 1670 to 
1699 I examined the 1686 Port Book: a year of peace which Nuala 
Zahediah had already worked on for the Colonial trade.20 Exports and re-
exports in the sixteenth and seventeenth century are harder to identify. 
Fewer Port Books for exports survive, and many only list cloth exports. 
Where possible, proximate years are averaged to reduce the impact of 
short-term variations. This has been possible for the 1630s, 1660s and 
the samples from 1699 onwards. Full details of the Port Books used are 
given in Appendix A. Fortunately, for the eighteenth century, the Customs 
Ledgers all survive and I use the three-year sample periods that Davis 
pioneered: 1699-1701, 1722-1724, 1752-1754 and 1772-1774.21   
Compiling figures for medical drug imports also presents 
methodological problems. One crucial question is what counts as a 
medical drug. The Customs’ Books of Rates which set out the notional 
values for goods on which taxes were calculated included a distinct sub-
section of ‘drugs’ from 1604 onwards.22 However, not every item in that 
sub-section was used as a medical drug. A number of items were 
primarily used for other purposes, whether as dyes and pigments 
(verdigris, cerussa, vermillion), perfumes (ambergris, musk, civet, myrrh), 
ornament (coral and other precious stones), pleasures (tobacco, 
pistachios), cooking ingredients (cumin seed, coriander seed, long 
pepper, green ginger) or for various manufacturing or industrial processes 
(gum arabic, sticklack, mercury). These items were frequently also used 
medicinally, but it seems reasonable to assume that it was not medicine 
that determined the scale of demand for them, and that any changes in 
consumption of these commodities might well result from quite different 
                                                 
19 See Davis 1954, p. 155-7. I use the totals by volume rather than the valuations Davis 
discusses. 
20 Zahedieh 1994. 
21 TNA, CUST 3, 3-4, 24-26, 52-54, 72-74; Davis 1962. 
22 Commissioners of Customs 1604, Sig.Cv-D2r. 
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imperatives. Moreover, certain new and unusual drugs were not included 
in the ‘drug’ section of the book, wormseed for example, and many drugs 
were missed out completely and appear in the Port Books with prices 
estimated ‘ad valorem’ (at value) on an ad hoc basis.  
In order to focus on changes in medical consumption, I sub-divide 
imports into two sample groups of commodities. The first is based on the 
‘drugs’ section listed in the 1660 Rate Book and the 1725 addendum.23 
This ‘Rate Book Drugs’ sample includes the full range of medical and 
non-medical items listed there. The second, ‘Medical Drugs’ sample 
includes only those substances that were primarily used in medicine. In 
its fullest form this includes medical drugs that were not listed in the rate 
book but were imported at value, and excludes those commodities which 
were heavily used for other purposes. For reasons explained below, the 
discussion focuses on those which overlap with the Rate Book. The full 
contents of the samples are listed in Appendix B. The most significant 
differences between the two samples is the exclusion of dyestuffs, 
precious stones, perfumes and spices from the ‘Medical Drugs’ sample. 
The selection process is inherently subjective – in particular, scents and 
preservatives overlapped in this period - but the trends described below 
are robust to changes in the content of the medical drug sample. 
Another major problem is measuring the trade in such a highly 
varied and extensive set of commodities. Imports are largely recorded by 
volume only until 1699. Both price and volume are available for most 
imports thereafter.  In order to outline long-run trends in drug imports and 
consumption, I revalue drugs using constant prices taken from the two 
sets of official customs valuations that were used to define the samples 
as a rough solution to the problem of aggregating different commodities 
over a long period of time. Customs’ prices theoretically reflect the price 
                                                 
23 A Subsidy granted to the King of Tonnage, & Poundage, 1660, pp. 44-56; An Act for 
Rating Such Unrated Goods, 1725, pp. 156-9. 
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of the commodities at first cost in their place of purchase, not the sale 
price in London, and these values therefore have only a loose connection 
to the nominal wholesale value of imports in any year.24 In practice, drug 
valuations appear to have been higher than the wholesale price, thus 
increasing the effective rate of tax and inflating the value of imports.25 
The availability of customs’ prices is a further constraint. For 207 drugs, I 
use official valuations taken from the 1660 rate book; these drugs account
for the bulk of trade.
 
 
 
 
y 
                                                
26 However, because the range of medical drugs 
being imported expanded in this period, relying on 1660 prices alone 
would undervalue imports in the latter part of the period. Many new drugs
were assigned official customs valuations in 1725, and another 67 prices
are taken from this source.27 The effect of their inclusion is shown in table
1; as can be seen, the overall trends in imports are not substantiall
changed until the 1720s, after which they produce a slightly higher growth 
rate, as one would expect given the chronology of their entry into the 
Book of Rates. There is some under-counting where volumes were not 
recorded for drug imports, but the value of these consignments was 
generally small.28 The same prices are used here for re-exports and 
exports. The majority of the data discussed below should thus be taken 
as being in 1660 prices. In addition, for comparison with other series, data 
on imports are also presented as valued by customs’ officials on entry for 
the period from 1699. 
Unfortunately, customs’ valuations were not recorded for all 
imported medical drugs. Some drugs were too obscure or too new to be 
 
24 Davis 1954, pp. 157-8; Schumpeter 1960, pp. 1-9.For a good discussion of the 
difficulties in valuing trade, see: Smith 1995. 
25 See table 6. 
26 A Subsidy, 1660. 
27 An Act, 1725. 
28 Including imports without volumes at the nominal value assigned to them by customs 
on entry would have little effect on the aggregate series. They would contribute more 
than one percent to a series based on medical drugs with values in the 1660 and 1725 
Rate Books on only two occasions: 1609 (2.4%) and 1722-24 (4.2%).  
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valued. Fortunately, so far as can be established, this has a limited 
impact on the aggregate pattern, and these drugs can be excluded from 
the main discussion without substantially altering the overall picture. For 
those medical drugs without customs valuations, one can estimate the 
effect they would have on the value of the imports in two ways. Fifteen 
commodities in the medical drugs sample were imported regularly enough 
that a valuation can be constructed using the average of the ‘Ad Valorem’ 
estimations made by Customs officials in the later three eighteenth 
century samples (1722-1774).29 When these values are used, this group 
of drugs never exceed four percent of the value of all medical drug 
imports in the eighteenth century, or half a percent in the seventeenth 
century.30 For another fifty four medical drugs, customs officials only 
recorded cash valuations. Although extensive, this group never exceed 
one percent of the value of imports over the two centuries.31  
These practical and methodological challenges mean that the data 
presented should be seen as a set of rough estimates, proxies for a set of 
real changes that we cannot now fully recover. Although values are 
discussed for convenience, it is the rates of change that are most reliable. 
The problems are particularly obvious for the aggregate data on drugs as 
a category, but even the figures for individual drugs presented in 
Appendix C need to be treated with care. 
 
 
                                                 
29 Although notionally actual prices, the Customs’ ad valorum estimations quickly 
became fixed. 1722-74 was a time of relatively little change in official prices (unlike 
1699-1701) and therefore gave a large sample from which to work, despite their 
greater chronological distance from the 1660 rate book: Clark 1938; Davis 1962, p. 
285. 
30 In 1699-1701, they would contribute 3.8% to a series based on medical drugs with 
values in the 1660 and 1725 Rate Books. For 1722-24, 1752-54, and 1772-74, the 
equivalent figures are 2.6%, 2.4%, 2.5%. 
31 See Appendix B for a full list of drugs imported. 
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Drug Imports 
Between the late sixteenth and the late eighteenth centuries, 
English drug imports increased substantially. Annual totals for imports are 
given in table 1. Both imports of commodities classified as ‘drugs’ in the 
rate books and the narrower sample of ‘medical drugs’ increased 
massively between 1567 and 1774, rising by around two orders of 
magnitude.  By the 1770s, medical drug imports were running at around 
£100,000 a year, fifty times greater than the £1,000 to £2,000 a year 
common two centuries earlier.  Drug imports grew much more rapidly 
over this period than imports in general, which increased by roughly 
twelve times.32 
 
[Insert table 1 near here] 
 
The growth in medical drug imports was concentrated in the 
seventeenth century. In the second half of the sixteenth century, the 
quantity of drugs imported was small and relatively stable. In the years for 
which we have data, 1567, 1588-89, and 1600, the value of imports of 
medical drugs ranged around one and two thousand pounds a year. 
There was no obvious trend of growth or decline in the volume of trade in 
this period, as was the case for English imports in general. 
Signs of growth are visible in 1609, and from the 1620s to the 
1660s drug imports increased substantially. In 1629, the peak year in our 
sample before the 1680s, the volume of imports was £25,774, over ten 
times greater than the average for the late sixteenth century. The figures 
for 1617-24, 1633 and 1638 suggest a slightly more modest level of 
imports was normal, but even they were consistently five times higher 
than the earlier norm. Such annual variations are unsurprising for trade. 
The data for the 1660s, although based on summary figures, suggest that 
                                                 
32 Imports were c. £1 million in 1600, and £13 million in 1772-74: Davis 1962, p.300. 
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trade in drugs had expanded further. Imports in 1662-8 were higher than 
had been normal in the 1620s and 1630s (although not dissimilar to 
1629). In the later seventeenth century there was a further substantial 
increase in the volume of medical drugs imported. Although by no means 
smooth, the rate of growth was high across the seventeenth century as a 
whole. The level of imports in 1699-1701 was 27 times higher than a 
century earlier.33 
Over the eighteenth century, the volume of medical drugs imported 
grew much more slowly. Imports actually fell between 1700 and 1723. 
They rose again by the 1750s, before apparently stagnating at around 
twice the level at the start of the century. Even with three year averages, 
this oscillation is not surprising given the effect that relatively small 
volumes of highly priced drugs could have on the totals. Over the century, 
the growth in medical drugs was much lower than the 217 per cent 
increase in the level of English imports in general.34 Imports of the wider 
customs category of ‘Rate Book Drugs’ grew at roughly the same rate, 
with an expansion in the importation of black lead, borax, sandalwood, 
and turpentine in particular. In 1772-74, these non-medical ‘drugs’ made 
up four of the five ‘drugs’ imported in largest quantities. Rhubarb was the 
only ‘medical’ drug among the five most significant drug imports by value, 
at fifth place. 
 
[insert table 2 near here] 
 
The use of constant prices to aggregate imports makes it important 
to consider whether the pattern of imports could be an artefact of the 
price level in 1660. We can explore this in several ways, and their effect 
                                                 
33 Calculated using the averages given in table 4. Growth rates were fastest in the first 
part of the century: 866% for c.1600-c. 1630 compared to 177% from 1665 to c.1700. 
34 Growth calculated from nominal values: Davis 1962, p. 300. 
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on the level of imports is summarized in table 2. For the eighteenth 
century, we can measure imports using the nominal value of imports as 
assessed and recorded by customs officials on entry. These were, in 
practice, a roughly constant set of official prices from the early eighteenth 
century (the totals are in table 1, columns 3 and 6). The trajectory of 
imports over the eighteenth century does look somewhat more optimistic 
on this measure and the dip from 1700 to 1720 disappears. However, the 
change in the overall value of imports was little different: the ratio of 
imports in 1772-74 compared to 1699-1701 was 2.3, compared to 1.8 
when estimated at 1660 prices. Note that when imports are totalled using 
nominal values they are worth only around half the amount when valued 
at the 1660 prices, indicating a substantial fall in the price that the 
customs’ officers applied to these drugs. We can also compare trends 
over the full period using official prices from earlier and later in our period. 
For most frequently imported drugs, we can use the average valuations 
from the later three eighteenth century samples (1722-1774).35 As can be 
seen in table 2, the levels of growth observed in the eighteenth century 
with these prices are very similar to those found with 1660 prices. The 
faster rate of growth in the seventeenth century reflects the narrower 
sample of imports: if we calculate growth rates using 1660 prices for the 
same sub-sample of medical drugs the ratios are very similar.36 To see 
the effect on imports of using earlier prices, we can use official prices 
from the 1604 Rate Book. In this case, as table 2 shows, the levels of 
import growth were little different from those found using 1660 prices. Our 
account of growing drug imports therefore appears to be robust to 
changes in the price level. This exercise further suggests that growth of 
imports was not biased towards those drugs that were becoming 
                                                 
35 See n. 29 for an explanation of the methodology. 
36 When the medical sample at 1660 prices is restricted to those drugs which appear in 
the sample with Ad Valorem prices the ratio of imports in 1600:1700 is 60.7, and 
1630:1700 is 110.9. 
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relatively cheaper: if that were the case, we would expect lower estimates 
of import growth when using eighteenth century prices. Either the fall in 
price over this period appears to have affected drugs more or less 
indiscriminately, or demand was relatively unresponsive to price. 
On their own, however, import figures are a limited guide to English 
medical consumption. The crucial issue for our understanding of the drug 
trade’s effect on consumption is the value of re-exports. It was in these 
centuries that England emerged as an international entrepôt, and many of 
the drugs and other commodities imported were simply passing through 
on their way to other destinations.   
Re-export levels are obscure before 1700. Nonetheless, some 
figures can be constructed for a few select years. For the period before 
1640, only four surviving Port Books offer a reasonable picture of re-
exports and exports.37 We have no good basis on which to estimate the 
proportion of trade by English and Alien merchants, so must rely on 
combining proximate years. Although re-exported imports are not 
differentiated from English produce in the Port Books, it is possible to 
identify drugs that were not grown or produced domestically; of course, 
England could and did import drugs that were also grown there, such as 
wormseed and saffron. In table 3 these crude estimates for re-exports are 
compared to the imports discussed above. 
 
[insert table 3 near here] 
 
Around 1600, England seems to have retained only a small share 
of the medical drugs it imported. Re-exports were worth two thousand six 
hundred pounds: substantially more than the value of medical drugs 
imported around 1600, and almost two-thirds of the value of imports in 
                                                 
37 An earlier port book for 1576 survives, but it is unclear whether this covers all or 
some merchants. 
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1609. Even in the wider Rate Book drugs sample, imports and re-exports 
roughly balanced. The export Port Book for 1599 records English 
merchants alone exporting a greater value of medical drugs than would 
arrive in 1600, largely due to the re-export of large quantities of 
Sarsaparilla (£1,700) and Benjamin (£483). By the 1630s, re-exports 
amounted to only around a fifth of the value of drug imports with a much 
larger share of imports retained for English consumption. The margin of 
error in these estimates is large given the wide annual variations and 
unmatched sample years, and the figure for retained imports in the 1630s 
is probably an over-estimate. Nonetheless, it seems reasonable to 
conclude that the rate of growth in English drug consumption in these 
decades may have been even higher than suggested by the import data 
alone.  
From 1640 to 1699 no useful information about re-exports survives. 
From 1699 onwards, however, the Customs records include extensive 
data on both exports and re-exports. These remain high. As can be seen 
in table 3, around half of drug imports were re-exported. However, as the 
total size of the drug trade had grown substantially, the volume of medical 
drugs retained for consumption was now much larger. By the start of the 
eighteenth century, domestic consumption was more than twice the level 
in the 1630s. Tellingly, given that retained imports around 1600 could not 
exceed the total of imports, these figures imply that by 1700 the level of 
English medical drug consumption was at least fifteen times higher than a 
century earlier. 
After 1700, medical drug consumption followed a very different 
trajectory. From 1699 to 1774, the volume of medical drugs retained 
appears to have grown slowly, with a decline in the 1720s. The wider rate 
book drug sample continued to grow rapidly, reflecting the demand for 
minerals and dyes in England’s expanding manufacturing sector. While 
imports doubled, the volume of foreign medical drugs retained for 
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consumption in England was only around forty percent higher in the 
1770s than in 1700. The crucial transformation in demand occurred in the 
seventeenth not the eighteenth centuries. 
These figures are based on official records. Some of the 
moderation in growth over the eighteenth century may be in part 
explained by the striking increase in customs duties in this period. Initially 
taxed at five per cent of a fixed, notional value, customs duties increased 
substantially from the late seventeenth century onwards. By the mid-
eighteenth century, duties had increased to 20-25 per cent on many 
drugs.38 Given drugs’ low bulk and high value, they were an obvious 
target for smuggling; this would be less of a problem for the bulkier and 
lower value items in the wider rate book drug sample. The Parliamentary 
Committee set up in the 1780s to examine frauds against the revenue 
reported that ‘a considerable proportion of the Drugs imported from the 
East Indies and from China is exported to the Continent of Europe for the 
drawback, in order to be afterwards re-landed clandestinely in this 
kingdom, together with what can be smuggled also from the Danes, 
Swedes and Dutch’.39 Consumption may have risen in the eighteenth 
century but been concealed from the official record. However, it is unlikely 
that smuggling could obscure a level of growth of the order of magnitude 
observable in the seventeenth century. Even if half of the drugs 
consumed in the eighteenth century were smuggled, this would suggest 
only just over a doubling of consumption – small beer compared to the 
explosive fifteen-fold growth in the century before.40 
                                                 
38 Duties on drugs were complicated. Moreover, as the Ad Valorem estimates from the 
eighteenth century were generally lower than the earlier Book of Rates valuations the 
effective rates of taxation may in fact have fallen. For rates and calculations see: Saxby 
1757; Baldwin 1770. See also: Davis 1966, pp. 307-11; Ormrod 2003. 
39 House of Commons, 1782-1802, XI, p. 291. 
40 Smuggled tea may have accounted for three times the volume of legal imports, but 
even if drugs were smuggled at that rate the argument still holds: Ashworth 2003, pp. 
176-8. 
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While foreign imports and re-exports are the most visible part of 
this story, exports cannot be neglected entirely. Export figures for medical 
drugs are hard to establish for much of the period and, as far as we can 
tell, England’s ability to produce raw drugs of interest to the international 
market was limited. Unprocessed drug exports centred on a small cluster 
of raw or partially processed materials with a wide range of applications, 
primarily quicksilver, white and red lead. While having medical 
applications at the time, these mainly served non-medical purposes. From 
the later seventeenth century onwards we can, however, identify a rise in 
English exports of processed medicines. These are normally listed in the 
customs records as ‘apothecary’s wares’. From other sources we know 
that proprietary medicines could be entered under that heading, but it is 
likely that traditional compound medicines and processed simples (non-
compounded medicines) were also included.41 In the 1686 Port Book, a 
few entries are described as ‘medicines’, ‘spirits of scurvy grass, or 
compound waters’, while in the 1699-1701 Customs Ledgers, ‘plague 
water’, Daffy’s Elixir, Epsom salt and spirits of scurvy grass, are recorded. 
Later in the eighteenth century, this level of detail unfortunately 
disappears. It is difficult to value this trade. In 1663/9, an average of 
16,330 lb of apothecary’s wares were exported. By 1699-1701 this 
amount had risen to 70,815 lb (around £1,300 at official prices). The 
valuation used by the Customs’ officers was £2 per hundredweight, but 
this is far below the wholesale price. For a few items exported by Anthony 
Daffy, the manufacturer of Daffy’s Elixir, we can compare the customs’ 
valuation with the actual wholesale price. Notionally, Daffy should have 
paid a 5 percent tariff. In practice, he paid between 1 and 1.6 per cent, 
suggesting the degree of undervaluing at the docks. 42 By the late 
                                                 
41 Haycock and Wallis 2005, pp. 24-25. 
42 TNA, E 190/72/1. On 11 July 1677 three consignments of apothecary wares from 
Daffy are noted (under the name of William Ball, who acted for him in the port): one, for 
120 bottles that Daffy priced at £15 was taxed at 4s; the other two Daffy had valued at 
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eighteenth century, exports of apothecary’s wares had grown 
dramatically. In the 1770s, an average of over 1,300,000 lb. (£23,259 at 
official prices) was being exported – almost twenty times the amount at 
the start of the century. Export-oriented drug production had become a 
reasonably-sized industry in England: by way of comparison, in 1772-74 
grain exports were valued at £37,000, hat exports at £110,000, and 
cottons at £221,000.43 
Total values for drug imports only tell us so much. The kinds of 
drugs imported suggest more about London’s role in this trade and the 
characteristics of medical supply and demand more generally. Given 
London’s high re-export rates, and the impossibility of chronologically 
matching imports and exports before 1699, we cannot assume that this 
represents changes in English demand.  However, it should give some 
indication of changes in consumption across Europe and its colonial 
dependencies, given London’s role in funnelling commodities into these 
markets. 
One of the obvious features of the medical drug trade was the very 
wide range of commodities imported. The number of different types of 
medical drugs imported each year ranges from lows of 4 in 1604 and 11 
in 1600 to highs of 142 in 1686 and 174 in 1699-1701. The average 
number of different kinds of drugs rose over the period from 29 in the late 
sixteenth century, to 66 between 1620 and 1640, and a remarkable 143 
types between 1699 and 1774. Only 15 of the 230 items listed in the drug 
section of the 1604 Rate Book were not recorded as being imported at 
                                                                                                                                               
£28 10s and £30 and both were taxed at 8s (f. 158r). On 17 Sept 1677, one shipment 
of ‘Apothecarys wares’ taxed  at 4s.which had been priced at £19/10/00 by Daffy (f. 
218r).  On 2 November 1677, one shipment of ‘Apothecarys wares’ taxed at 8 s. which 
had been priced at £24 by Daffy (fol. 265v): Haycock and Wallis 2005, pp. 44, 137, 
151. 
43 Davis 1962, p. 302. 
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some point in the period.44 In addition to these figures for the number of 
types of drugs imported in reasonable bulk, we must allow for the 
importation of smaller quantities of drugs that were not listed individually. 
The diversity of the early modern published pharmacopoeias was, it 
seems, reflected in the variety of drugs available. 
While consumers’ demand for a wide range of medicinal 
substances was met to some degree, a much smaller group of drugs 
made up the majority of imports. Table 4 lists the ten leading ‘medical 
drugs’ (measured at official values) in each period. Even though the 
variety of drugs increased over this period, in every period apart from 
1699-1701 this small sub-set made up around two-thirds to three quarters 
of all drugs imported. Indeed, the five most common drugs regularly 
constituted around half of imports by value.  
 
[insert table 4 near here] 
 
The leading medical drugs imported changed substantially over the 
period. However, a core of drugs were prominent throughout. Senna 
featured among the most popular in all periods, and China Roots, 
Benjamin, Rhubarb and Sarsaparilla were present in all but one or two 
periods, indeed, rhubarb headed the list three times. All were medical 
staples of well-known efficacy.45 Among the other drugs imported in large 
amounts in the late sixteenth century and early seventeenth centuries, 
wormseed remained a common import (see Appendix C). The other major 
drugs (spica celtica, sanguis draconis, agaric, and ireos) in the early 
period fell away dramatically in importance. This is probably a product of 
                                                 
44 These are: Anacardium;  Blatta Bizantiae;  Cytrauge;  Daucus;  Generall;  
Mirabilanes condited;  ol Scorpions;  Ossa de Corde cervi;  Sal alkali;  Sandiver;  
Soldonella;  Terra lemnia;  Thlaspi semen;  Turbith Thapsiae  
45 Grieve suggests that China Root is a synonym for Galangal (Grieve 1931, p. 339), 
but they were regarded as distinct drugs in the seventeenth century (see: 
Commissioners of the Customs 1604; Pechey 1694, p. 232). 
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the low level of trade in the early period making the ranking process 
rather more volatile than later on. For the only manufactured drug on the 
list, the plague and poison remedy theriac, which also fell out of the list of 
leading imports quickly, import substitution was also a real possibility, as 
was the effect of the decreasing frequency of plagues.  
The changes in the kinds of drugs imported into England were thus 
largely additive.  It would be the easy availability of medicines in 1800, not 
the types of drugs imported, that would have most surprised a physician 
from two centuries earlier. Four-fifths of the leading drugs imported 
between 1567 and 1774 were sufficiently familiar that they were listed in 
the first Pharmacopoeia Londinensis published by the College of 
Physicians in 1618.46 The most significant change in the types of drugs 
imported over this period was a product of the development of trade 
routes, not the result of a shift in medical theory or practice.  
The changes in the reported origins of England’s drug imports are 
shown in figure 1. English customs’ records only provide the port at which 
a cargo was embarked for its final passage to England, so this data does 
not fully capture the shift in the origins of drug imports. Thus, Asian drugs 
imported by the Dutch East India Company would be recorded as 
originating in the Netherlands, while early imports from India or the Levant 
might be recorded as Italian or Flemish. This is less important where 
drugs originated from England’s American and Caribbean colonies, as 
they were generally imported directly. Drugs from South and Central 
America, however, would often be transhipped and so appear as 
‘European’. A further minor complication is that ports of origin were not 
always recorded or discernable in the original Port Books of the 
seventeenth century.   
                                                 
46 Of 30 ‘leading drugs’ in table 4, 24 were listed (two others were waters): College of 
Physicians 1618. 
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Even with these limitations, some of the major changes in the 
structure of the English drug trade are clear in figure 1. Two new sources 
of imports emerged, both helping to displace the Northern European axis 
of Flanders and the Netherlands that had previously dominated English 
trade. First, from the early seventeenth century onwards, Asian 
commodities were reaching England directly, in the ships of the East India 
Company. Large-scale commerce in rhubarb, opium, and olibanum 
(frankincense) in particular was one of the major changes in the English 
drug trade. Second, from small beginnings in the late seventeenth 
century, the Americas became an important source of drugs from the 
1720s onwards. The majority of these drugs, such as guaiacum, 
sarsaparilla and Jesuits’ Bark, came from Central and South America; 
fewer came from the English colonies in North America, although there 
were a handful of exceptions such as Virginia Snakeroot and Pink root. 
Among American drugs, one stands out for its exceptional importance: 
Jesuits Bark, which made up 40 per cent of all direct American drug 
imports into England over the whole period. Perhaps less expected is the 
emergence of a substantial trade in mineral waters, both generic ‘spa 
water’ and Pyrmont water, notionally from the Westphalian spa town. 
What implications did this shift in the availability of foreign 
medicines have for patients in early modern England? It is difficult to 
move from aggregate imports to the sick-bed. Medical practices were 
diverse and there were multiple uses and modes of processing and 
preparing for drugs. However, some crude impression of the impact of 
rising drug imports on their availability to the population at large can be 
obtained from translating imports into courses of treatment. Table 5 uses 
standard pharmacopeia and medical texts to estimate the number of 
‘treatments’ of five of the most common imported drugs. I consciously use 
‘treatment’ loosely here. The amounts prescribed for different illnesses 
varied. Some drugs, such as sarsaparilla, were primarily used in 
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compound form, and it is rarely clear if an author was describing the 
volume necessary for a cure, for one among a series of doses, or for the 
production of a medicine that would treat multiple cases. As far as 
possible, the low and high estimates presented here are the volumes that 
authors indicated as necessary to treat a case. Even so, achieving a 
purge with senna or rhubarb is a relatively precise goal compared to 
treating syphilis with sarsaparilla. Conversely, someone might use purges 
regularly, whereas they were more likely to use Jesuits bark or 
sarsaparilla sporadically as occasional illnesses demanded. These 
estimates are based on the retained imports of these drugs, assuming 
half are re-exported: re-exports for individual drugs fluctuate wildly even 
in the eighteenth century.47  
 
[insert table 5 near here] 
 
While the figures in table 5 are speculative at best, they do suggest 
that the increase in the consumption of medicine over this period must 
have extended far beyond the elite. In the late sixteenth century, even the 
most common imported drugs, such as senna, were still only arriving in 
sufficient volume to treat a few thousand people. Only wormseed (on a 
low dose) offered the possibility of mass consumption in the first half of 
the seventeenth century and an indigenous production and export trade 
appears to have emerged for wormseed. Prescriptions, inventories, 
household accounts and institutional records show that some imported 
drugs were being consumed in England during the sixteenth century. 
However, the vast majority of English demand for medicines must have 
been met by remedies using domestically produced drugs.  By the mid-
                                                 
47 Even with three year averages, when imports and re-exports are compared for 
specific drugs we find that re-exports can exceed imports. In this sample, this occurs 
with rhubarb (1770s), wormseed (1740s, 1770s), and sarsaparilla (1720s). 
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seventeenth century, this had changed dramatically: already by the 
1660s, senna imports might equate to between thirty thousand and three-
quarters of a million purges for a population of around 5.2 million. A 
century later, an average of almost one (low) dose of senna per every two 
people was imported into England. The figures for rhubarb and 
sarsaparilla give similar impressions. Similarly, it is surely indicative of a 
mass market for Jesuits’ Bark that the amount imported in the 1720s and 
1750s could have provided between two hundred thousand and a million 
treatments. 
While this evidence of dosages imported indicates the appearance 
of a mass market for medicines, the ability of the sick to utilize different 
medical treatments, and the impact of their decision to consume, is a 
function of price as well as availability. Evidence on the prices of drugs is 
even scarcer than evidence on levels of imports. However, for the 1660s 
to the 1730s and for a few years in the 1790s some bulk wholesale prices 
for drugs sold in the London market are available from surviving Price 
Courants, essentially price newspapers for merchants.48 Prices for nine 
prominent drugs are presented in table 6. The prices have been deflated 
using Allen’s Consumer Price Index for London, which contains a basket 
of food based on a labourers’ diet, with 1666-75 taken as the base year.49 
Inflation has little effect until the 1790s. 
Despite capturing the last period of rapid expansion in drug imports 
in the later seventeenth century, there is no clear trend in drug prices 
between the 1660s and 1700. The prices of Benjamin, Senna, Opium, 
Scammony were remarkably stable. Wormseed and rhubarb increased in 
price, the latter by more than 100 percent. The prices of Aloes Socotrina 
and Sarsaparilla did both fall by roughly a third, but Jesuits Bark was the 
only drug to see a very large fall in price (although its initial high price is 
                                                 
48 Price 1954, pp. 240-9.  
49 Allen 2001. 
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based on a single price report) of the kind that might be expected when 
the quantity imported grows so quickly. By the end of the eighteenth 
century, the real price had fallen for five drugs: Aloes Socotrina, 
Benjamin, Jesuits Bark, Opium, Sarsaparilla. However, Rhubarb and 
Senna cost around the same as in the 1660s, while Scammony was twice 
as expensive and Wormseed was no longer listed. An un-weighted 
average of the relative change of the drug prices in table 6 suggests that 
prices in the 1790s were on average 15 percent lower than in the 1660s: 
a small change when medical drug imports were ten times higher.  
Unfortunately, the Price Courant price data only begins after the 
most dramatic growth in drug imports had ended. Figures from earlier in 
the century suggest that prices for some drugs may have fallen 
significantly by the 1660s. In the early 1630s, the wholesale price for 
Senna (42d/lb), rhubarb (253d/lb), Benjamin (80d/lb), Opium (160d/lb) 
and Sarsaparilla (80d/lb) were all markedly higher than later in the 
century.50 For these five drugs, prices fell on average by around 50 
percent between the 1630s and 1660s. As these are wholesale druggists’ 
prices, not port prices, they may overstate the decline, but it seems likely 
that the initial expansion in drug imports was accompanied by substantial 
price falls.  
 
 
Conclusion 
Taken together, the shifts in price and imports show the key 
characteristics of the evolution of the English medical drug trade over this 
period. In particular, the seventeenth century seems to have been the 
period of greatest expansion in supply. While drug prices fell initially, it 
                                                 
50 Prices: Henry Box, [Account Book], Yale University, Beineke Library, Osborn b211 
(average, 1629-33); Anonymous Apothecaries’ Stock Lists, Wellcome Library MS 7646. 
Senna, (n=24), Rhubarb (n=11), Opium (n=2), Sarsaparilla (n=13), Benjamin (n = 4). 
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seems that the demand for medicines outstripped supply over the last half 
of the seventeenth century, keeping prices buoyant despite increasing 
volumes. Large scale domestic consumption of imported drugs was firmly 
established by the start of the eighteenth century: the use of imported 
medicines cannot have been restricted to the elite by that point. The next 
century saw far less change in overall levels of consumption. Individual 
medicines, such as Jesuits bark, boomed, but more generally both prices 
and retained imports grew slowly. As the persistent growth in the levels of 
imports and re-exports underlines, England’s involvement in the 
international drug trade continued to expand rapidly; but this was driven 
by foreign, not domestic, demand. Over the period, medicinal drugs 
showed little signs of the relative decline experienced by for the fine 
spices, or the ‘demystification’ recently suggested by Halikowski Smith.51 
This chronology of rising medical consumption puts medical drugs among 
the earliest group of exotic imports to boom: for most other groceries, 
Shammas identifies the major rise as occurring in the eighteenth century; 
only tobacco was available in sufficient quantities for mass consumption 
in the later seventeenth century.52   
Evidence of a dramatic expansion in drug imports into England 
provides us with a new perspective on changes in the consumption of 
healthcare in this period. To the extent that drug consumption offers a 
rough indicator for wider shifts in demand for medical services, it seems 
that the turning point in English consumption came in the early decades 
of the seventeenth century, and the period of greatest growth had ended 
by 1700. As figure 2 shows, the timing and scale of the change in drug 
imports closely parallel Mortimer’s data on the increasing resort to 
medical practitioners in Southern England, suggesting that this reflects a 
national trend, and indicate that his data fortuitously capture the main 
                                                 
51 Halikowski Smith 2008, pp. 416-9. 
52 Shammas 1990, p. 77-82. See also: Wallis 2008, pp. 45-9. 
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transition in consumption. The trajectory of prices sketched out above 
adds weight to this interpretation, as the rising levels of demand Mortimer 
found would have helped prevent prices from falling as imports expanded. 
This chronology also matches the main institutional changes in regulation, 
notably the establishment of the Society of Apothecaries in 1617 with its 
aspiration to monopolize the sector, the appearance of bulk contracting 
for drug supplies for the navy and East India Company, and the mass 
production of proprietary remedies. 53   
That drug imports and payments for medical goods and services 
grew in parallel offers another way to interpret the expansion in medical 
consumption in this period. Mortimer emphasizes improvements in the 
productivity of medical practitioners, achieved particularly through their 
easier access to the sick, in his explanation for how the supply of 
healthcare could keep up with the growth in demand.54 He also highlights 
a turn to chemical medicines. However, while the supply of chemical 
medicines cannot be usefully observed through the Customs’ records, 
given the range of industrial uses of their raw materials, the ongoing 
popularity of Galenic simples provides little evidence of a change in the 
content of medicine that might be responsible for shifts in consumption.55 
More significantly, the increasing supply of drugs suggests that much of 
the increase in expenditure in Probate Accounts may have been due to 
purchases of medicines rather than services.56 Economies of scale are 
easier to achieve in pharmacy than direct medical or surgical assistance, 
allowing us to assume more moderate increases in the workload of 
medical practitioners. 
                                                 
53 Wallis 2002, pp. 217-21. 
54 Mortimer 2009, pp. 204-5. 
55 Mortimer 2009, p. 65. 
56 Probate Accounts are too terse for this distinction to be made in most cases, and as 
Mortimer emphasizes the provision of ‘physic’ was the most common service: Mortimer 
2009, p.73. 
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The kinds of medical drugs imported also changed over this period. 
However, the changes were mainly an expansion in the pharmacopoeia, 
rather than a displacement of older medicines by new drugs. There were 
some significant additions. Notably, in Jesuits’ Bark we observe a change 
that probably increased the objective efficacy of medicine in treating 
some kinds of disease. But the therapeutic range was marked more by 
continuity than change. A shift in scale of this kind must, though, have 
had wide implications. In rapidly becoming widely available in quantities 
that were radically different to earlier periods, drugs, like other new 
consumer goods, presented new consumption possibilities and allowed 
new sensibilities and modes of behaviour to develop. Imported drugs 
linked domestic and commercial medical practice to extensive supply 
networks and commercial retailers such as apothecaries and druggists. 
They separated the materials of medicine from the direct encounters and 
personal knowledge of farm and field. In use, they intertwined foreign 
materials with foreign knowledge, increasing the utility of medical 
practitioners’ specialized knowledge. The increasing availability of 
medicines, old and new, perhaps offers a way to understand why the sick 
might look to the market rather than to kitchen physic for their health. The 
emergence of mass drug consumption marked a revolutionary shift in the 
form, practice and implications of healthcare. 
 26
Bibliography: 
 
1660, A Subsidy Granted to the King of Tonnage & Poundage, London: 
John Bill [Wing, E2314A] 
1725, An act for rating such unrated goods and merchandizes London: 
John Baskett  [ESTC N050443] 
Anagostou, S. 2007, ‘The international transfer of medicinal drugs by the 
Society of Jesus’, in Egmond, F., Hoftijzer, P.  and Visser, R. (eds) 
Carolus Clusius, Amsterdam: Royal Netherlands Academy of Arts 
and Sciences.  
Ashworth, W. 2003, Customs and Excise: Trade, Production and 
Consumption in England 1640-1845. Oxford: Oxford University 
Press. 
Baldwin, S. 1770, A Survey of the British Customs, London: J. Nourse. 
Berg, Maxine, 2005, Luxury and Pleasure in Eighteenth-Century Britain, 
Oxford: Oxford University Press. 
Clark, G. N. 1938, Guide to English Commercial Statistics 1696-1782, 
London. 
College of Physicians 1618, Pharmacopeia Londinensis, London: John 
Marriott.  
Commissioners of Customs 1604, The Rates of Marchandizes, London: 
G.E. [STC (2nd ed.) 7690.5] 
Cook, H. J. 2008, Matters of Exchange: Commerce, Medicine, and 
Science in the Dutch Golden Age, New Haven: Yale University 
Press. 
Davis, R. 1954, ‘English Foreign Trade, 1660-1700’, Economic History 
Review, 7, 150-166 
Davis, R. 1962, ‘English Foreign Trade, 1700-1774’, Economic History 
Review 15,  285-303. 
 27
Davis, R. 1966, ‘The Rise of Protection in England, 1689-1786’, 
Economic History Review, 19, 306-317. 
De Vries, J. 2008, The Industrious Revolution, Cambridge: Cambridge 
University Press. 
De Vries, J. and Van der Woude, A. 1997, The First Modern Economy: 
Success, Failure and Perseverance of the Dutch Economy, 1500-
1815, Cambridge: Cambridge University Press. 
Dietz, B. 1971, The Port and Trade of Elizabethan London, London: 
London Record Society.  
Dube, P. 1704, The Poor Man's Physician and Surgeon, London: T. 
Newborough. 
Findlay R. and O’Rourke K. 2007, Power and Plenty: Trade, War and the 
World Economy in the Second Millennium, Princeton: Princeton 
University Press. 
Grieve, M. 1931, A Modern Herbal, London: Jonathan Cape. 
Halikowski Smith, S. 2008, ‘“Profits sprout like tropical plants”: A fresh 
look at what went wrong with the Eurasian spice trade between 
c.1550–1800’, Journal of Global History 3, 389–418. 
Haycock, D. B. and Wallis P. 2005, Quackery and Commerce in 
Seventeenth-Century London, London: Medical History 
Supplement No. 25. 
Hoon, E. E. 1937, The Organization of the English Customs System, 
1696-1786, New York: D. Appleton-Century Co. 
House of Commons, 1782-1802, ‘Reports from the Committee on Illicit 
Practices Used in Defrauding the Revenue [1783, 1784]’, in 
Reports of the House of Commons, XI. 
Leong, E. 2006, ‘Medical Remedy Collections in Seventeenth Century 
England’, DPhil.Thesis, University of Oxford. 
McCants, A. E. C. 2007, ‘Exotic Goods, Popular Consumption, and the 
Standard of Living,’ Journal of World History, 18, 433-464. 
 28
Millard, A. M. 1956, ‘The Import Trade of London, 1600-1640.’ Ph.D. 
Thesis, University of London. 
Monro, A. 1781, The Works of A. Monro, Edinburgh. 
Mortimer, I. 2009, The Dying and the Doctors: The Medical Revolution in 
Seventeenth-Century England, Woodbridge: The Boydell Press, 
2009. 
O’Rourke K. and Williamson, J. G. 2002, ‘After Columbus: explaining the 
global trade boom 1500-1800’, Journal of Economic History,  62, 
417-456. 
O’Rourke K. and Williamson, J. G. 2009, ‘Did Vasco da Gama matter for 
European Markets’, Economic History Review, 62, 655-84. 
Ormrod, D. 2003, The Rise of Commercial Empires: England and the 
Netherlands in the Age of Mercantilism, 1650-1770, Cambridge: 
Cambridge University Press. 
Pechey, John, 1694, The Compleat Herbal of Physical Plants, London. 
Peck, L. L. 2005, Consuming Splendor: Society and Culture in 
Seventeenth-Century England, Cambridge: Cambridge University 
Press. 
Pelling, M. and Webster C. 1979, ‘Medical Practitioners’, in  Webster C. 
(ed), Health, Medicine and Mortality in the Sixteenth Century, 
Cambridge: Cambridge University Press, 165-235. 
Pelling, M. 2003, Medical Conflicts in Early Modern London, Oxford: 
Oxford University Press. 
Power, M., Lewis, F. and Ascott, D. 1998, Liverpool Community, 1649-
1750 [computer file], Colchester: UK Data Archive [distributor], SN: 
3882 
Price, J. M. 1954, ‘Notes on Some London Price-Currents, 1667-1715,’ 
Economic History Review, 7, 240-250. 
Quincy, J. 1782, Pharmacopiea Officinalis & Extemporanea, London: T. 
Longman. 
 29
Roberts, R. S., 1965, ‘The Early History of the Import of Drugs into 
Britain’, in Poynter F. N. L. (eds), The Evolution of Pharmacy in 
Britain, London: Pitman, 165-185. 
Saxby, H. 1757, The British Customs, London, 1757. 
Schumpeter, E.B. 1960, English Overseas Trade Statistics, 1697-1808, 
Oxford: Clarendon Press. 
Smith, P. H. and Findlen, P. (eds) 2002, Merchants & Marvels: 
Commerce and the Representation of Nature in Early Modern 
Europe, New York: Routledge. 
Smith, S.D., 1995, ‘Prices and the value of English Exports in the 
Eighteenth Century’, Economic History Review, 48, 575-90. 
Stobart, A. 2008, ‘The Making of Domestic Medicine’, Ph.D. Thesis, 
Middlesex University. 
Wallis, P. 2002, ‘Medicines for London: The Trade, Regulation and 
Lifecycle of London Apothecaries, c.1610-c.1670’, D.Phil Thesis, 
University of Oxford. 
Wallis, P. 2008, ‘Consumption, Retailing, and Medicine in Early-Modern 
London’, Economic History Review, 61, 26-53. 
Wear, A. 2000, Knowledge and Practice in English Medicine, 1550-1680, 
Cambridge: Cambridge University Press. 
Willan, T. S. (ed) 1962, A Tudor Book of Rates, Manchester: University 
Press. 
Wilson, G. 1709, A Compleat Course of Chymistry, London. 
Wilson, A. 1995, The Making of Man-Midwifery: Childbirth in England, 
1660-1770. Cambridge: Harvard University Press. 
Winterbottom, A. 2009, 'Producing and using the Historical Relation of 
Ceylon', The British Journal for the History of Science, 42, 515-538  
Zahedieh, N. 1994, ‘London and the Colonial Consumer in the Late 
Seventeenth Century’, Economic History Review 47, 239-261. 
 30
Table 1: Drug Imports, 1567-1774 
 
  Rate Book 'Drugs' Medical Drugs 
  
1660 & 
1725 prices 
£
Percentage 
using 1725 
prices
Nominal 
value at 
entry
1660 & 
1725 prices
Percentage 
using 1725 
prices 
Nominal 
value at entry
 £ £ £ £ £ £ 
1567 2,412 0  1,807 0  
1588-89 2,291 0  1,385 0  
1600 2,412 0  796 0  
1609 5,813 0  3,929 0  
1617-24 12,858 0  8,002 0  
1629 38,578 0  25,774 0  
1633 28,326 0  17,734 0  
1638 33,815 0  18,678 0  
1662-8 78,304 0  31,346 0  
1685 94,243 1  48,496 2  
1699-1701 115,212 4 51,042 55,383 7 24,215
1722-24 121,227 27 64,906 50,695 20 28,457
1752-54 220,718 10 159,370 96,112 16 58,441
1772-74 233,134 9 174,452 97,089 14 55,093
 
 
Notes: Imports are valued in sterling using the Price series described in the text. 
Where Port Books survive for only English or Denizen merchants, annual totals are 
inflated by the proportions of all trade in the hands of each group. Trade figures are 
derived from Millard 1956. The multipliers are: 1567, 1.57; 1600, 4.34; 1609, 2.70; 
1617, 3.03; 1621, 1.27; 1624, 6.25; 1629, 1.16. In practice, drug imports did not always 
parallel the share of all trade: in 1633 Aliens imported 12.9% of all commodities rated in 
the drug section as against 11% of all imports, while in 1637 they imported 3.8% of 
drugs against 12% of all imports. 
For two years, only partial years survive: For 1589, only six months survive and the 
total was thus doubled; for 1633, only 11 months of the Denizen Book survives and the 
total was inflated by 1.09. 
Several years are combined to provide better estimates. For 1588-89, where proximate 
years for English and Denizen merchants were available, they were summed to 
produce an annual total. For 1617-24, the Alien Books for 1617 and 1624 were 
averaged and summed with the English Book 1624. For 1662-8, an average of the two 
sets of summary totals is given. For 1699 onwards, three year averages are given.  
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Table 2: Ratios of Medical Drug Imports Using Different Price Series 
 
 1660 
official 
prices 
Nominal 
values 
1722-74 Ad 
Val prices 
1604 official prices
1600:1700 27.2   63.2 31.8 
1630:1700 2.7   78.7 2.7 
1700:1770 1.8 2.3 2.0 1.8 
1720:1750 1.9 2.1 1.9 1.7 
 
Source: as described in the text. 
 
 
Table 3: English Re-exports and Consumption of Imported Drugs 
 
 Rate Book 'drugs' Medical Drugs 
  Imports Re-Exports Retained Imports Re-Exports Retained
   £ £  £  £  £   £ 
c.1600 3,505 3,053 452 2,037 2,633 -596
c.1630 28,646 5,916 22,731 17,644 3,060 14,584
         
1699-1701 115,212 67,600 47,611 55,383 23,169 32,214
1722-24 121,227 42,022 79,205 50,695 30,812 19,883
1752-54 220,718 94,981 125,737 96,112 51,272 44,841
1772-74 233,134 74,987 158,148 97,089 51,600 45,489
 
 
Note: 
Re-export figures for the 1600s are based on the 1599 Denizen and 1605 Alien Port 
Books; figures for the 1630s are based on the 1632 Alien and 1639 Denizen Port 
Books. Import figures for c. 1600 are an average of 1588, 1600 and 1609, and for c. 
1630 are an average of 1629, 1633 and 1638. 
The figure for Retained Imports is calculated from Imports less Re-Exports. Negative 
figures imply an imbalance of trade between sample years. For 1600 and 1630 Exports 
were assumed to be re-Exports if the commodity was not produced in England. From 
1699 onwards, re-exports are separately recorded in the Customs Ledgers.  
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Table 4: Major Imports, Ranked by Value 
  1566-
1610 
1617-
38
1662-
68
1685 1699-
1701
1722-
24 
1752-
54
1772-
74
Theriac 1  
Sarsaparilla 2 6 6 10  3 2
Wormseed 3 1 5 9 6  
China Roots 4 7 8 3 1 2 10
Senna 5 5 7 5 7 4 7 5
Spica Celtica 6  
Benjamin 7 2 3 5 4 4
Cassia Fistula 8  
Sanguis Draconis 9  
Agaric 10  
Opium  2 6  
Rhubarb  3 3 1 9 6 1 1
Scammony  4 9 7 9 
Spikenard  8 10  
Ireos  9  
Gum Tragacanth  10  
Aloes Cicotrina  1 2 2 10 
Ambergrease  4  
Manna  4 7 6 8
Aloes Epatica  8 3 9
Storex Calida  10  
Bezoar Stone (of the 
East Indies) 
 4  
Oyl Anniseed  5  
Lignum Vite  8  5 6
Jesuits Bark  1 2 7
Sassafras Roots  8 
Jalap   8
Camphor, Unrefined   9
Sulphur Vivum   3
Pyrmont Water   10
Top 10 as proportion 
of all imports 
0.79 0.81 0.83 0.68 0.61 0.76 0.77 0.72
Top 5 as proportion 
of all imports 
0.65 0.70 0.57 0.51 0.40 0.59 0.60 0.49
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Table 5: Retained Imports as Dosage, Thousand Doses. 
 Senna Rhubarb Wormseed Sarsaparilla Jesuits’ Bark 
 Higha  Lowb Highc  Lowd Highe Lowf Highg  Lowh Highi Lowj 
 3 oz 1 dr 2 dr 1 sc 2 oz 0.5 dr 4 oz 2 oz 2 oz 4 dr 
1567 2 42 0.5 3 2 76   
1589 0.5 12 0.1 0.6 0.8 27 0.2 0.4 
1617-241 10 244 35 209 39 1247 3 6 
1630-381 8 190 49 292 42 1356 5 10 
1662-68 32 757 77 461 46 1,482 2 4 
1685 51 1,213 215 1,289 21 669 25 50 8 33
1699-1701 42 1,002 50 298 53 1,696 17 33 6 25
1722-24 70 1,676 55 330 20 646 2 4 228 913
1752-54 61 1,475 582 3,493 0 0 75 149 296 1,186
1772-74 120 2,880 304 1,823 1 41 110 219 112 449
 
Notes: 
Retained imports are based on imports less 50 percent to allow for re-exports: this was 
the average proportion of drugs re-exported 1699-1774.   
1. Figures for 1617-24 are an average of 1617 and 1624, and those for 1630-1638 are 
an average of 1630, 1633 and 1638 
Dosages are from: a. Dube 1704, p. 11; b. Pechey  1694, p. 328; Quincy 1782, p. 163; 
c. Pechey 1694 p. 320, and Wilson 1709, p. 224; d. Quincy 1782, p. 168; e. Quincy 
1782, p. 610; f. Dube 1704, p. 130; g. Wilson 1709, p. 294; h. Pechey 1694, p. 394; i. 
Wilson 1709, pp. 231-2; j. Dube 1704, p. 238; Monro 1781, p. 664. 
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Table 6: Drug Prices: Official Import Rates and Wholesale Prices  
 Customs Official Prices Wholesale Drug Prices in London 
 
Rate 
Book
1660
Ad 
Valorem 
1722-74 
1666-
75 1676-85
1696-
1706 1731-35 1796-99
 d/lb d/lb d/lb d/lb d/lb d/lb d/lb
Aloes Socotrina 60 5.3 30.8 24.3 17.3 34.1 24.0
  (23) (17) (29) (1) (7)
Benjamin 40 6 34.1 30.2 33.3 48.7 17.5
  (48) (25) (19) (1) (7)
Jesuits bark 30 31.4 - 128.5 60.8 61.4 26.5
  (1) (26) (3) (38)
Opium 80 31.4 34.1 30.2 33.3 48.7 17.5
  (25) (18) (29) (30) (26)
Rhubarb 240 146 79.7 200.6 187.0 257.4 81.7
  (23) (24) (25) (30) (19)
Sarsaparilla 40 12 33.6 25.6 20.3 39.9 23.4
  (24) (18) (28) (30) (10)
Scammony 160 54 110.3 126.7 122.7 163.6 240.0
  (24) (31) (54) (2) (26)
Senna 30 20 32.3 19.5 31.4 34.1 35.1
  (51) (43) (66) (1) (10)
Wormseed 40 42 30.8 44.5 50.5 54.2 
  (33) (36) (46) (14) (0)
CPI  1.00 1.03 1.01 0.93 1.58
        
 
Note: Number of observations given in parentheses below mean of price for each 
period. Prices are relative to 1660 levels using Allen’s CPI series reported in the last 
row. Nominal prices can be obtained by multiplying the price by the CPI. The Ad 
Valorem price is the average valuation made by Customs in the three sample periods 
from 1722-24, 1752-54 and 1772-74. 
Sources and periods: Prix Courrant des Marchandises a Londres (1671-3); Prises of 
Merchandise in London (1672-4); The Merchants Remembrancer (1680-1); Le 
Memorial Des Marchands, Whiston (1681-5); Prices of Merchandise in London (1683); 
Prix Courrant des Merchandises a Londres (1668-1684); The Prices of Merchandise in 
London (1667-1696); Whiston's Merchants Weekly Remembrancer (1691-1707); 
General Remark or Miscellanies (1708); Prix Courant de Marchandises A Londres, 
Mahieu (1699-1715); Weekly Journal or British Gazetteer (1716); Proctor's price-
courant (1696-1731); Gentleman's Monthly Intelligencer (1731-1735); Price Current 
Boston (1784); Price Current of Goods Imported from North America (1798); Price 
Current of Leghorn (1798-9); Price Current of Goods Exported/Imported (1781-1799); 
Prince's London Price Current (1796-1799). 
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Figure 1: Origins of Drug Imports, by Region 
 
 
Note: 'Other' includes drugs from Africa, Northern Europe and the British Isles 
 
Figure 2: Drug Imports to England and Demand for Medical Services 
 
 
  
Note: Data corrections given in table 1. Percentage of Probate Accounts of status 
groups A & B purchasing medical and nursing services in East Kent: Mortimer, ‘Medical 
Assistance’, ii, p. 23. 
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Appendix A: List of Customs Sources, 1567-1699. 
a. Imports 
Year Period Reference Merchants 
1567-8 30 Sept 1567-24 Sept 1568 E. 190/4/2 (Dietz, 1971) Denizen 
1588-9 30 Sept 1588 - 6 April 
1588; Apr 1588 - 28 Sept 
1589 
E190/7/8; E190/8/1 Denizen 
1589 4 Apr 1589 –25 Sept 1589 E190/8/2 Alien 
1599-1600 1 Oct 1599- 27 Sept 1600 E190/11/1 (also E190/11/3) Alien 
1609 29 Dec 1608- 24 Dec 1609 E190/14/5 Alien 
1617 30 Dec 1616-24 Dec 1617. E190/21/4 Alien 
1621 29 Dec 1620-24 Dec 1621 E190/24/4 Denizen 
1624 1 Dec 1623-24 Dec 1624 E190/27/1 Alien 
1630 24 Dec 1629-24 Dec1630 E190/34/2 Denizen 
1633 29 Dec 1632-24 Dec 1633 E190/37/8 Alien 
1633 29 Dec 1632-27 Nov 1633 E190/38/1 Denizen 
1638 24 Dec 1637-24 Dec1638 E190/41/1 Alien 
1638 24 Dec 1637-24 Dec1638 E190/41/5* Denizen 
1662-63 Michaelmas 1662 to 
Michaelmas 1663 
CO 388/2, f.7 All 
1668-69 Michaelmas 1668 to 
Michaelmas 1669 
CO 388/2, f.13 All 
1686 24 Dec 1637-24 Dec 1638 E190/143/1 Denizen 
1686 24 Dec 1637-24 Dec 1638 E190/137/2 Alien 
 
NB: I excluded 1574-5 as it contains no ‘medical’ items, and 1604 which only covers 3 winter months.  
* Significant parts (c.10 per cent) of this book are damaged and illegible 
 
b. Exports 
Year Period Reference Merchants 
1576 Easter - Michaelmas 1576 E190/6/4 All 
1598-99 Michaelmas 1598-
Michaelmas 1599 
E190/10/11 Denizens 
1605 4 Jan 1604/5- 23 Dec 1605 E190/12/7 Aliens 
16221  29 Dec 1621-24 Dec 1622 E190/25/2 Aliens 
1632 29 Dec 1631-24 Dec 1632 E190/37/6 Aliens 
1639 Christmas 1638- Christmas 
1639 
E190/43/62  Denizens 
1662-63 Michaelmas 1662 to 
Michaelmas 1663 
CO 388/2, f.7 All 
1664 Incomplete: 12-27 Jan 
1663/4; 16 April-2 Sept 
1664; 7 -26 Nov 1664. 
E190/50/2 Denizens 
1668-69 Michaelmas 1668 to 
Michaelmas 1669 
CO 388/2, f.13 All 
1686 24 Dec 1685-24 Dec 1686 E193/139/1 Denizen 
1686 24 Dec 1685-24 Dec 1686 E193/141/5 Alien 
 
NB: I have excluded 1669-70 Alien exports as it covers a brief period. 1 Another surviving book for this 
year (E190/25/9) records cloth exports only. 2 This volume is damaged and a significant amount of entries 
for October (c.25 per cent) and November (c.50 per cent) are illegible or lost
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Appendix B: Medical Drug Sample 
Medical Drugs sample 
Medical Drugs with valuations from 1660 Rate Book:  
Acacia; Acorus; Adiantum; Adiantum Album; Agaric; Agaric, Trimmed; Agnus 
Castus; Alcanet; Alchermes, Confectio; Alkermes Syrrup; Aloes Cicotrina; Aloes 
Epatica; Ambergrease; Ameos Seed; Anacardium; Angelica; Aristolochia; 
Asaraum; Aspalathus; Assafoetida; Balaustium; Balsalum Artificial; Balsalum 
Natural; Bayberries; Bdellium; Ben Album Or Rubrum; Benjamin; Bezoar Stone 
(E Indies); Bezoar Stone (W Indies); Bolus Communis & Armoniacus; Bolus 
Venis; Bunkins, Holliwortles, Or Pistolachia; Callamus; Camphor, Refined Or 
Not; Caneri Oculus; Cantharides; Carolina; Carpo Balsami; Carrabe; Cassia 
Fistula; Castoreum; Cetrach; China Roots; Ciperus Longus & Rotundus; Civet; 
Coculus Indiae; Coloquintida; Cortex Guiaci; Cortex Mandragorae; Cortex 
Tamarisci; Cortex Winteranus; Costus; Cuscuta; Cyclamen; Cyperus Nuts; 
Cytrauge; Diagredium; Dictamnus Leaves; Dictamnus Roots; Dictamnus, 
Unspec; Doronicum; Ebustum; Elleborus (Black or White); Epithium; 
Euphorbium; Fennel Seed; Fenugreek; Flory; Folium Indiae; Fox Lungs; 
Galanga; Galbanum; Generall; Gentiana; Grana Pinae; Guinea Grain; Gum 
Animi; Gum Armoniac; Gum Caramen; Gum Carannae; Gum Elemni; Gum 
Guiaci; Gum Hederae; Gum Juniper; Gum Opoponax; Gum Sandrack; Gum 
Sarcocoll; Gum Serapium; Gum Taccamahaccae; Gum Tragacanth; 
Hermodactilis; Hypocistis; Incense; Ireos; Jalap; Jujubes; Labdanum; Lapis 
Calaminaris; Lapis Contrayerva; Lapis Hematitis; Lapis Judaicus; Lapis Tutiae; 
Leaves Of Violet Or Flowers; Lentiscus, Or Xylobalsamum; Lignum Aloes; 
Lignum Asphaltum; Lignum Nephriticum; Lignum Rhodium; Lignum Vite; 
Locust; Lupines; Manna; Mastick Red; Mastick White; Mechoacan; Milium Solis; 
Mirabilanes; Mirabilanes Condited; Mithridatium Venetiae; Mummia; Myrtil 
Berries; Nardus Celtica; Nigella; Nitrum; Nux Cupressi; Nux De Ben; Nux 
Vomica; Ol Amber; Ol Almonds; Ol Bay; Ol Ben; Ol Mace; Ol Petroleum; Ol 
Rosemary; Ol Scorpions; Ol Spike; Ol Terbinthinae; Opium; Orabus; Orange 
Flower Ointment; Orcant Or Almiet; Origanum; Osipium Huirredum; Ossa De 
Corde Cervi; Pellitorie; Perrosen; Pionyseed; Pix Burgundiae; Polipodium; 
Polium Montanum; Pomegranate Pills; Poppyseed; Psyllium; Radix Contra 
Yerva; Radix Esula; Radix Peonae; Rhaponticum; Rhubarb; Rose Leaves; 
Rosset; Sal Germine; Sandaracha; Sandiver; Sanguis Draconis; Sanguis Hirci; 
Sarsaparilla; Sassafras Roots; Sassafras Wood; Saunders White; Saunders 
Yellow; Scammony; Scordium; Scorzonera; Sebestens; Seler Montanus; 
Semen Cumeris or Cucurbis Citru, Melon; Senna; Soldonella; Spermaceti 
Course Oily; Spermaceti Fine; Spica Celtica; Spica Romana; Spikenard; 
Spodium; Squilla; Squinathum; Staechados; Stavesaker; Stibium; Storex 
Calida; Storex Liquida; Sulphur Vivum; Tamarindes; Terra Lemnia; Terra 
Sigillata; Thlaspi Semen; Tornsall; Treacle; Treacle Of Venice; Trocisci De 
Viper; Turbith; Turbith Thapsiae; Viscus Quercinus; Wormseed; Zedoaria;  
 
Medical Drugs with valuations from 1725 Rate Book:  
Adeps Ursi; Ambra Liquida; Auriculae Judae; Baccae Alkakengi; Balsam 
Capivia; Bitumen Judiacum; Capita Papaverum; Chamaepitys; Chelae 
Cancrorum; Cornu Cervi Calcinatum; Cornu Unicornu; Cortex Cariophyllorum; 
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Cortex Elutheris; Cortex Limonum Vel Aurantiorum; Cowitch; Cranium 
Humanum; Dens Apri; Dens Equi Marini; Eboris Rasurae; Eryngo; Flores 
Chamaemeli; Flores Meliloti; Granadilla Peruviana; Gum Copal; Hungary Water; 
Hypocacuana; Jesuits Bark; Lapis Hibernicus; Lapis Hyacinthus; Lapis 
Ostiocolla; Lapis Spongiae; Ol Carui; Ol Chemical; Ol Cimyni; Ol Origanum; Ol 
Perfumed; Ol Rhodium; Ol Thyme; Ol Cariophyllorum; Ol Anniseed; Ol 
Jessamin; Ol Juniper; Ol Sassafras; Ol Cinamon; Pompholix; Radix Bistortae; 
Radix Cassumuniar, Not Of The East Indies; Radix Enulae Campanae; Radix 
Mei; Radix Phu; Radix Tormentillae; Rezina Scamonii; Rezini Jallapi; Rhinhurst; 
Rosa Solis; Saccarum Saturne; Sal Prunellae; Sal Succini; Sal Tamarisci; Sal 
Volatile Cornu Cervi; Sevum Cervinum; Snake Root; Spa Water; Spiritus Cornu 
Cervi; Ungulae Alcis; Water, Cordial; Water, Pyrmont. 
 
Rate Book Drugs: 
This sample includes the Medical Drug  sample listed above, plus these 
commodites with valuations from 1660 Rate Book: 
Almonds Bitter; Alum Plume; Alum Roche; Amomi Semen; Antimonium Crude; 
Argentum Vivum; Arsenic (Or Rosalgar); Barley Huld; Black Lead; Blatta 
Bizantiae; Borax In Paste; Borax Refined; Cambogiam; Cardomomes; 
Carraway Seed; Carthamus Seed; Cassia Lignea; Cerussa; Chrystal, In Broken 
Pieces; Ciceres; Cinabrium; Copperas, Blue; Copperas, White; Coral (Red And 
White); Coral Whole; Corriander Seed; Cortex Caperum; Cubebs; Cumin Seed; 
Daucus; Gardenseed; Ginny Pepper; Grana Tinctorum; Green Ginger; Gum 
Arabeck; Gum Lack; Gum Seneca; Isinglas; Juniper Berries; Lapis Lazuli; 
Lentils; Litharge Of Gold; Litharge Of Silver; Marmelade; Mercury Precipitate; 
Mercury Sublimate; Musk; Musk Cods; Myrrh; Nutmegs Condited; Olibanum; 
Orpiment; Panther; Pearl, Beaten; Pepper Long; Pistacias; Precipitat; Prunellos; 
Quicksilver; Rubia Tinctorum; Sal Alkali; Sal Armoniacum; Sal Niter; Saunders 
Red alias Stock; Seeds for garden; Sponges; Succus Liquoritiae; Talk, Green; 
Talk, White; Tumerick; Turpentine Common; Turpentine Of Venice; Umber; 
Varnish; Verdigrease; Vermilion; Vitriolum Romanum; White and Red Lead. 
 
And these with valuations from the 1725 Rate Book: 
Aqua Fortis; Barbados Tar; Cinnabaris Nativa, not of the East Indies; 
Colophonia; Cream Of Tartar; Essence Of Lemons; Fechia; Lapis Magnetis; 
Lapis Nephriticus; Lapis Rubinus; Lapis Sapphirus; Lapis Smaragdus; Lapis 
Topazae; Mother Of Pearl Shells, Not Of East Indies; Ol Nucis; Ol Palm; Ol 
Vitriol; Sal Tartari; Sal Vitrioli; Sal Volatile Armoniaci; Salop; Spiritus Vitrioli; 
Tartarum Vitriolatum; Turpentine of Germany.  
 
Additional ‘Medical’ items imported,  
These commodities were not rated  and are not used in samples: 
Alligante; Althea; Amber Water; Angelica Water; Apoplectick Balsome; Balsam 
Tolu; Balsam, Peruvian; Balsam, Spanish; Bulter Pomatum; Cardas Water; 
Cascarilla; Cassia Buds; Cassia Stones; Cinamon Water; Cinquefoil Seed; 
Confection Of Hyacinths And Alkermes; Eagle Stones; Ginseng Root; Goa 
Stone; Granadilla Wood; Gum Of Almonds; Hartshorn; Lapis Aquilegii; Lapis 
Ashocula; Lapis Granati; Lemon Water; Nux Indica; Ol Capenia; Ol Cloves; Ol 
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Medicinal; Ol Physical; Opoponax; Orange Flower Water; Orange Ointment; 
Origano Oyl; Orrass Roots; Orvietan; Oyl Cloves; Physick Water; Pink Roots; 
Quatro Semina Frigidorum; Queen Of Hungary'S Water; Radix Cyprus; Radix 
Ffsarium; Radix Jessamin; Radix Tiberus; Radix, Columba; Scincus Marinus; 
Scorpions; Semen Ben; Semen Gingslam; Semen Secelees; Succus Cassia; 
Surgeon's Instruments; Syrup Of Maidenhair; Treacle Of Genoa; Tuberose 
Roots; Vipers; Water, Aniseed; Water, Broom; Water, Citron; Water, Ratafie; 
Worm Powder. 
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Appendix C: Annual Values of Main Imported Drugs 
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Note: Drugs included are the ‘top ten’ drugs by value for the periods given in Table 3. 
Partial totals for 1588 (English merchants) and 1589 (Alien merchants) are summed. 
For 1662-8 the total is an average of 1662-3 and 1668-9. For 1699-1774, the three 
year average for each sample period is given. No other adjustments have been made 
to compensate for the partial coverage of the early years. i. Port Book only contains 
imports by English Merchants; ii. Port Book only contains imports by Foreign 
Merchants. 
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